Department of Urology, Mayo Clinic, Rochester, MN.
Department of Cardiovascular Research, Huntington Medical Research Institutes, Pasadena, CA; Department of Medicine, Keck School of Medicine at University of Southern California, Los Angeles.
Mayo Clin Proc. 2024 Sep;99(9):1500-1517. doi: 10.1016/j.mayocp.2024.06.002. Epub 2024 Aug 8.
The Princeton Consensus (Expert Panel) Conference is a multispecialty collaborative symposium dedicated to optimizing sexual function and preserving cardiovascular health. The Fourth Princeton Consensus Conference was convened on March 10-11, 2023, at the Huntington Medical Research Institutes in Pasadena, California. Princeton panels I to III addressed the clinical management of men with erectile dysfunction (ED) who also had cardiovascular disease. Thirteen years since Princeton III, Princeton IV builds on previous foundations in several key areas. Mounting evidence supports the need for providers to treat men with ED as being at risk for cardiac events until proven otherwise. Algorithms for the diagnosis and treatment of ED are updated with new recommendations for coronary artery calcium scoring for advanced cardiovascular risk stratification. Optimization of oral phosphodiesterase type 5 inhibitors in the treatment of men with ED and cardiovascular disease is thoroughly explored, including recent evidence of potential cardioprotective effects of these drugs.
普林斯顿共识（专家小组）会议是一个多学科合作研讨会，致力于优化性功能和保护心血管健康。第四届普林斯顿共识会议于 2023 年 3 月 10 日至 11 日在加利福尼亚州帕萨迪纳的亨廷顿医学研究所召开。普林斯顿小组 I 至 III 专门讨论了同时患有心血管疾病的勃起功能障碍（ED）男性的临床管理。自普林斯顿 III 会议以来已经过去了 13 年，普林斯顿 IV 在几个关键领域建立了以前的基础。越来越多的证据支持提供者将患有 ED 的男性视为存在心脏事件风险，直到有其他证据证明并非如此。ED 的诊断和治疗算法得到了更新，包括对冠状动脉钙评分进行高级心血管风险分层的新建议。深入探讨了在治疗 ED 和心血管疾病的男性中使用磷酸二酯酶 5 抑制剂的优化方案，包括这些药物可能具有心脏保护作用的最新证据。
